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During the development process of active or passive cardio-
vascular implants, such as ventricular assist devices or vascular 
grafts, extensive in-vitro testing is required. The aim of the study 
was to develop a versatile hybrid mock circulation (HMC) 
which can support the development of such implants that have 
a complex interaction with the circulation. The HMC operates 
based on the hardware-in-the-loop concept with a hydraulic 
interface of four pressure-controlled reservoirs allowing the in-
teraction of the implant with a numerical model of the cardi-
ovascular system. Three different conditions were investigated 
to highlight the versatility and the efficacy of the HMC during 
the development of such implants: 1) biventricular assist device 
(BiVAD) support with progressive aortic valve insufficiency, 2) 
total artificial heart (TAH) support with increasing pulmonary 
vascular resistance, and 3) flow distribution in a total cavo-
pulmonary connection (TCPC) in a Fontan circulation during 
exercise. Realistic pathophysiologic waveforms were generated 
with the HMC and all hemodynamic conditions were simulated 
just by adapting the software. The results of the experiments 
indicated the potential of physiologic control during BiVAD or 
TAH support to prevent suction or congestion events, which 
may occur during constant-speed operation. The TCPC geom-
etry influenced the flow distribution between the right and the 
left pulmonary artery, which was 10% higher in the latter and 
led to higher pressures. Together with rapid prototyping meth-
ods, the HMC may enhance the design of implants to achieve 
better hemodynamics. Validation of the models with clinical 
recordings is suggested for increasing the reliability of the 
HMC. ASAIO Journal 2019; 65:495–502.
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The typical development process of active and passive cardi-
ovascular implants, such as ventricular assist devices and vas-
cular grafts, consists of several steps. It starts with the in-silico 
modeling of the hydraulic properties to virtually test the im-
plant, continues with the in-vitro testing to verify the in-silico 
results with physical models before testing the device in vivo. 
In-vivo testing allows the validation of the performance of the 
implant in animals before proceeding with clinical testing and 
application. While in terms of pressures and flows in-silico hy-
draulic models and boundary conditions can be adjusted as 
desired to mimic a realistic hemodynamic scenario, such an 
adjustment is more demanding with in-vitro setups, which are 
required to accurately imitate real conditions.
Conventional hydraulic mock circuits to investigate the hy-
draulic properties of cardiovascular implants consist of tubes, 
open and air-trapped reservoirs, valves, and cardiac simulators 
to simulate hemodynamic conditions.1 However, undesired 
effects because of the fluid inertance may occur when tubes 
and valves are used, especially in the case of in-vitro imita-
tion of the cardiovascular system, which constitutes a very dy-
namic and complex environment. Thus, realistic waveforms of 
pressure and flow characteristics cannot be achieved at high 
fidelity. Furthermore, the versatility of such mock circuits is 
limited because hardware changes are required whenever dif-
ferent conditions are to be tested. Systems are thus required to 
evaluate different cardiovascular implants efficiently and in a 
versatile way with realistic hemodynamic waveforms.
Such systems have been presented earlier for the evalua-
tion of left ventricular assist devices (LVADs). Besides others,2–4 
Ochsner et al.5 used air and vacuum pressure-regulated reser-
voirs to mimic the left ventricular pressure (LVP) and the aortic 
pressure (AoP), which are computed by a numerical model of 
the cardiovascular system. This hybrid mock circulation (HMC) 
operates based on the hardware-in-the-loop (HIL) approach. It 
can be used to evaluate LVADs and their control algorithms. In 
HMCs, all components of the cardiovascular system are simu-
lated numerically. The reservoirs, which are the main hardware 
parts of the system, form the interface between the numerical 
model of the cardiovascular system and the LVAD. The nu-
merical model can be of almost unlimited complexity, for in-
stance, to mimic any desired input impedance of the arterial 
vasculature,6 which cannot be achieved with a conventional 
hardware-based system. Furthermore, if any physiologic feed-
back control mechanisms of compliances, resistances, etc. are 
desired, the HIL interface provides advantages in terms of com-
plexity; while with the numerical model the compliance value 
can be easily adjusted, in hardware-based loops, the amount 
of air in an air-trapped reservoir needs to be adjusted using a 
pneumatically controlled system for each reservoir.
In this study, the technology of the HMC developed earlier with 
two pressure reservoirs5 was extended to four reservoirs and the 
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numerical model adapted according to the specific investiga-
tion. This versatile HMC allows to test complex active and pas-
sive cardiovascular implants, such as biventricular assist devices 
(BiVADs), total artificial hearts (TAHs), and total cavopulmonary 
connections (TCPCs) for Fontan patients, i.e., patients with a sin-
gle-functional ventricle who underwent the Fontan procedure, 
i.e., the surgery where the caval veins are directly connected to 
the pulmonary arteries to palliate their symptoms yielding a TCPC.
Currently, 10–30% of LVAD recipients develop right ventric-
ular (RV) failure,7 and in many cases, a BiVAD support treatment 
is followed. The outcomes of BiVAD support with rotary blood 
pumps have been worse than with LVAD support.8,9 The fluid 
balance between the pulmonary and the systemic circulation is 
challenging with two pumps running at constant speeds. There-
fore, appropriate test setups to investigate new control methods 
of physical devices in an early development phase are required 
to verify in-silico methods to control and adapt the two pumps to 
each other and to the physiologic requirements of the circulation.
When the biventricular failure is treated with a TAH,10 the 
hydraulic performance of the device and its interaction with 
the cardiovascular system are crucial and should be evaluated 
at an early development phase using appropriate in-vitro facili-
ties. The lack of neurohumoral cardiac response during TAH 
support constitutes a challenge for any physiologic adaptation 
of the device to the demands of the patient11 and the control 
of the left/right fluid balance remains a challenging topic.12 Fi-
nally, in the case of Fontan patients with a TCPC, no power is 
added to the blood on the subpulmonary side and any pressure 
drop due to the geometry of the TCPC impedes a sufficient 
venous return.13 Simulated flow fields and pressure losses in 
the TCPC need to be validated in vitro with realistic flows and 
vascular impedances.
The versatile HMC developed can be employed for evaluat-
ing the performance of BiVADs and TAHs and their control 
algorithms, when interacting with the cardiovascular system. 
Furthermore, it allows the assessment of the influence of the 
TCPC geometry on Fontan hemodynamics, such as the resulting 
pressure losses, under various pathophysiological conditions.
Materials and Methods
In all three test cases presented, the same hardware setup 
was used and only the software part, i.e., the numerical model 
of the cardiovascular system, was adapted. Both hardware and 
software parts are described below and in the Supplemental 
Digital Content in detail (http://links.lww.com/ASAIO/A308).
Hardware
Figure 1 depicts a schematic overview of the hardware 
parts of the HMC developed, divided into the hydraulic and 
the pneumatic system. The hydraulic system consists of four 
pressure reservoirs (PR1–PR4) whose pressures are controlled 
by using pressurized air and vacuum based on pressure mea-
surements (PN2009, IFM Electronic GmbH, Essen, Germany). 
Additional hardware includes four ultrasound flow probes 
(CO.55/190, Sonotec Ultraschallsensorik Halle GmbH, Halle, 
Germany), four pressure transducers for monitoring inline 
pressures (TruWave, Edwards, Lifesciences, Irvine, CA, USA), 
and three reflux pumps (two Jabsco 18660 Series, Xylem 
Figure 1. Scheme of the hardware parts of the versatile hybrid mock circulation developed. It consists of four pressure reservoirs (PR1–
PR4), three reflux pumps (RP1–RP3), one VC, one VP, eight PTs, and four FPs. For the Fontan experiment, the dashed line (L2) replaces the 
solid line (L1). The RP3 is only used during the Fontan experiment. FPs, flow probes; PTs, pressure transducers; VC, vacuum chamber; VP, 
vacuum pump.
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Inc., NY, USA, and one S-pump, Xenios AG, Heilbronn, Ger-
many). The pneumatic system consists of one vacuum pump 
(ZL112-K15LOUT-E26L-Q, SMC Pneumatics, Tokyo, Japan), 
one vacuum chamber and proportional solenoid valves, one 
inlet valve (PVQ33-5G-23-01F, SMC Pneumatics) for con-
necting each reservoir with the compressed air from the net-
work supply, and two outlet valves (PVQ33-5G-40-01F, SMC 
Pneumatics) for connecting each reservoir with the vacuum 
chamber. These valves were controlled to achieve the desired 
pressures in the respective four reservoirs.
Software
Figure 2 presents the three different numerical models of 
the cardiovascular systems used in each test of this study. Each 
model consists of four main parts, the left heart (red), the right 
heart (blue), the pulmonary circulation (light gray), and the sys-
temic circulation (dark gray). The arterial and venous systems 
were simulated by five- and three-element Windkessel models, 
respectively, resulting in different arterial input impedances. 
In the TAH configuration, no active ventricular models were 
Figure 2. Electric analog of the numerical models of the cardiovascular system used in this study. Path 1 (P1) corresponds to the BiVAD 
test case, path 2 (P2) to the TAH test case, and path 3 (P3) to the TCPC test case. Gray lines indicate the interfaces of the respective implant 
to the numerical model. The additional control mechanisms for heart rate and maximum elastance are only used for the Fontan circulation 
based on Granegger et al.15 BiVAD, biventricular assist device; TAH, total artificial heart; TCPC, total cavopulmonary connection.
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employed. The lumped parameter models for the BiVAD and 
TAH cases were adopted from Colacino et al.14 Based on that 
model, control mechanisms for the unstressed venous volume, 
the systemic venous and arterial resistances, as well as the 
pulmonary arterial resistance, were implemented. For the uni-
ventricular cardiovascular system, the model was derived from 
Granegger et al.,15 which included control mechanisms for 
the systemic and pulmonary arterial resistance as well as the 
unstressed venous volume. Furthermore, heart rate (HR) and 
maximum elastance control mechanisms were incorporated, 
analogously to those reported.14 A detailed description of the 
model is provided in the Supplemental Digital Content (http://
links.lww.com/ASAIO/A308).
Active Cardiovascular Implant
Two HeartWare HVADs (Medtronic Inc., Minneapolis, MN, 
USA) were used for both the BiVAD and the TAH configura-
tion experiments. To control the HVAD speed, an in-house 
speed controller was developed based on a control board 
(LAUNCHXL-F28069M) with two DC drive stage modules 
(BOOSTXL-DRV8305EVM) both from Texas Instruments (Dal-
las, TX, USA) for the two motors of the pump. In both BiVAD 
and TAH configuration experiments, the HVAD speed was ei-
ther set at a constant value or controlled dynamically with a 
physiologic controller.
Test Case 1: Biventricular Assist Device Support 
During Aortic Valve Insufficiency
A pathologic circulation of an adult patient with biven-
tricular failure was simulated with reduced RV and LV ejec-
tion fractions of 30% and 20%, respectively.9 Both ventricles 
were supported with an HVAD whose speed was adjusted to 
yield a cardiac output (CO) of 5 L/min. Figure 3 (left) depicts 
the HVAD configuration on the HMC. A resistance element 
was added at the outflow of the RVAD to reduce the flow by 
increasing the pressure head across the pump while keeping 
the operating speed between 1,800 and 4,000 rpm.7
In this study, we simulated the implantation of the RVAD 
into the RV, unlike another possibility that is commonly re-
ported, which features RVAD implantation in the right atrium.7 
To investigate the fluid balance between the systemic and the 
pulmonary vasculature during BiVAD support, we simulated a 
transition from mild to severe aortic insufficiency (AI), which 
seems to occur in a large number of patients supported by 
continuous-flow VADs.16 For this purpose, the resistance of the 
aortic valve was adapted during baseline conditions to result 
in regurgitant fractions of less than 30% and greater than 50%, 
respectively.17
This transition experiment was conducted twice. First, both 
HVADs were operated at a constant speed such that 5 L/min 
were supplied to the pulmonary and the systemic circulation 
in the baseline condition, where left atrial pressure (LAP) and 
right atrial pressure (RAP) were 12.5 and 2.7 mm Hg, respec-
tively. For the second case, both HVADs were controlled to 
keep either preloads in a physiologic range. This algorithm was 
implemented to control the end-diastolic pressure (EDP) by 
a simple proportional controller, which increased the HVAD 
speed with increasing preload, as presented earlier18 and 
described in Equation 1:
N k Ndes edp ref ref EDP EDP= +( )- ,
where kedp is the proportional gain (rpm/mm Hg), EDPref is the 
set point EDP (mm Hg) defined during calibration, i.e., while 
adjusting the reference speed Nref (rpm).
Test Case 2: Total Artificial Heart Configuration Support 
During Increase of the Pulmonary Vascular Resistance
The same model of the circulatory system of test case 1 was 
used for test case 2 but without ventricles. The two HVADs 
were now serving as a TAH configuration, thus pumping from 
a passive left or right atrium to the aorta or the pulmonary ar-
tery, respectively. A fivefold pulmonary vascular resistance 
(PVR) increase from 0.1 to 0.5 mm Hg·s/mL was applied19 to 
simulate the clinical condition of pulmonary hypertension, 
which may occur in VAD patients20 and lead to fluid imbal-
ance problems. This experiment was conducted under two dif-
ferent control cases of the HVADs. First, they were operated 
at a constant speed, such that a pump flow and CO of 5 L/min 
resulted. Then, the experiment was repeated while the HVADs 
were controlled to keep the preloads in a physiologic range 
by controlling the LAP and RAP, i.e., by applying the control 
structure of Equation 1 and by replacing the EDP with LAP and 
RAP, respectively, see Figure 3 (left).
Figure 3. Left: Picture of the HMC during the BiVAD and TAH configuration experiments with the two HeartWare HVADs installed. Right: 
Picture of the HMC during the Fontan experiments with the three-dimensional-printed TCPC. AoP, aortic pressure; BiVAD, biventricular assist 
device; HMC, hybrid mock circulation; IVCP, inferior vena cava pressure; LAP, left atrial pressure; LPAP, left pulmonary arterial pressure; LVP, 
left ventricular pressure; PAP, pulmonary arterial pressure; RAP, right atrial pressure; RPAP, right pulmonary arterial pressure; RVP, right ven-
tricular pressure; SVCP, superior vena cava pressure; TAH, total artificial heart; TCPC, total cavopulmonary connection.
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Test Case 3: Total Cavopulmonary Connection 
Flow Distribution During Rest and Exercise
A rigid model of a TCPC was used as a passive cardiovas-
cular implant. The geometry was derived from a patient who 
followed Fontan completion. For this purpose, cardiovascular 
magnetic resonance imaging datasets were acquired from the 
patient.21 The TCPC geometry was three-dimensional-printed 
with Polyamide 12. The three-dimensional-printed TCPC ge-
ometry was evaluated when coupled with a numerical model of 
a univentricular cardiovascular system.15 That model includes 
closed-loop baroreflex and metabolic reflexes to simulate 
exercise. Increased power loss in the TCPC during exercise 
conditions has been reported to greatly influence the clinical 
outcomes of Fontan patients21 and thus requires investigations 
to develop new solutions. In our study, a baseline condition at 
rest was compared with an exercise level of three metabolic 
equivalents of tasks (METs) by recording the pressures and flow 
distribution within the TCPC, see Figure 3 (right).
Results
Test Case 1: Biventricular Assist Device Support 
During Aortic Valve Insufficiency
During constant-speed BiVAD support, the AI progression led 
to an increase in LV preload, with an LV EDP elevation from 
15 to 24 mm Hg, respectively (Figure 4). That preload increase, 
in turn led to an LVAD PF increase from 6.2 to 7.5 L/min, but 
the corresponding CO decreased from 4.9 to 4 L/min due to the 
increased regurgitant flow. The RVAD PF decreased by 1 L/min 
due to the RV preload decrease, which resulted from the blood 
volume shift to the pulmonary circulation as well as the after-
load increase. The RVAD speed remained at 2,200 rpm and as 
a result, excessive unloading with negative pressures and con-
sequent RV suction occurred (see RV pressure–volume (PV) 
loops in blue in Figure 5). In the case of physiologically con-
trolled pumps, the PS of the LVAD increased to 3,300 rpm and 
the RVAD PS decreased to 2,000 rpm during the AI progression. 
Negative pressures are also observed in Figure 5 in the RV PV 
loops in black and red. The reason for those was the limited 
ability of the pneumatic pressure controllers of the hydraulic in-
terface5 to accurately apply a positive pressure close to 0 mm 
Hg to the pressure tanks. Yet, they were not corresponding to 
suction. The LVEDP increased from 15 to 19 mm Hg at a CO of 
4.9 and 4.5 L/min, respectively. The LVAD PF increased to 9.5 L/
min, while the RVAD PF decreased to 4.5 L/min. The PV loops of 
the RV changed marginally, showing a slight preload decrease.
Test Case 2: Total Artificial Heart Configuration Support 
During Increase of the Pulmonary Vascular Resistance
In the constant-speed case, the RVAD flow decreased due to 
the PVR increase and the lack of speed adaptation, which led 
Figure 4. Measured and simulated signals during the biventric-
ular support test case. The signals of the measured pump speed 
and flow as well as the simulated valve flows of the AV and PV are 
depicted. AV, aortic valve; LVAD, left ventricular assist device; PV, 
pulmonary valve; RVAD, right ventricular assist device.
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Figure 5. Pressure–volume loops of the right (RVP–RVV) and 
left ventricles (LVP–LVV) during the biventricular support test 
case. Loops during mild and severe AI are depicted. The end-
diastolic (EDPVR) and end-systolic pressure–volume relationships 
(ESPVR) are also illustrated. AI, aortic insufficiency; LVP, left ven-
tricular pressure; LVV, left ventricular volume; RVP, right ventricular 
pressure; RVV, right ventricular volume.
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to a preload decrease for the LVAD (Figure 6). The LVAD speed 
did not decrease and, therefore, negative LAPs occurred at t 
>25 sec. With physiologic control, the LVAD speed decreased 
by approximately 400 rpm and the RVAD speed increased by 
200 rpm after the PVR increased, thus keeping an equal pump 
flow between the LVAD and the RVAD. The RAP and LAP 
remained almost constant, whereas the AoP decreased and the 
pulmonary arterial pressure (PAP) increased.
Test Case 3: Total Cavopulmonary Connection 
Flow Distribution During Rest and Exercise
At rest, the flow of the inferior vena cava (IVC) was three 
times greater than the one of the superior vena cava (SVC), see 
Figure 7. Due to the asymmetric geometry of the TCPC, the 
left pulmonary arterial (LPA) flow equaled 2.4 L/min and was 
0.5 L/min higher than the right pulmonary arterial (RPA) flow. 
The IVC and SVC pressures were equal, while the LPA pressure 
was 0.5 mm Hg higher than the RPA pressure. These differences 
were also observed during the exercise condition: The IVC 
flow increased by 1.5 L/min but remained three times larger 
than the one of the SVC. The difference between LPA and RPA 
slightly increased up to 0.8 L/min, while the LPA flow equaled 
3.6 L/min, thus keeping the flow ratio equal to that observed in 
rest conditions, i.e., approximately 55% for LPA and 45% for 
RPA flow. The SVC and IVC pressures increased by approxi-
mately 2 mm Hg and they remained equal with each other. The 
LPA and RPA pressures increased by approximately 1 mm Hg, 
Figure 6. In-vitro performance of a TAH configuration consist-
ing of two HeartWare HVADs and operating either at a constant 
speed or with physiologic control during an increase of PVR. The 
signals of the pump speeds and flows as well as of the LAP, the 
AoP, the RAP, and the PAP are depicted. AoP, aortic pressure; 
LAP, left atrial pressure; LVAD, left ventricular assist device; PAP, 
pulmonary arterial pressure; PVR, pulmonary vascular resistance; 
RAP, right atrial pressure; RVAD, right ventricular assist device; 
TAH, total artificial heart.
Figure 7. In-vitro results of the TCPC when interacting with the 
simulated Fontan circulation under 1 (left) and 3 (right) METs. The 
flows and pressures for the IVC and SVC, as well as the LPA and 
RPA, are depicted. The LVP and AoP are also shown in the bottom 
plots, as well as the HR increase from rest to exercise. AoP, aortic 
pressure; HR, heart rate; IVC, inferior vena cava; LPA, left pulmonary 
artery; LVP, left ventricular pressure; METs, metabolic equivalents of 
tasks; RPA, right pulmonary artery; SVC, superior vena cava; TCPC, 
total cavopulmonary connection.
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indicating a slightly elevated pressure drop during exercise. 
The LVP and AoP signals show that the HR increased from 
around 75 bpm at rest to around 105 bpm during exercise.
During all the experiments, the root-mean-square errors be-
tween the pressures computed by the numerical models and 
the pressures applied within the pressure reservoirs remained 
below 3 mm Hg.
Discussion
In this study, a new HMC was presented that allows the 
evaluation of the performance of complex active and passive 
cardiovascular implants. It is able to accurately apply the pres-
sures computed by numerical models to the hydraulic inter-
face used, thus enabling a reliable interaction between the 
implant and the model. It offers a high flexibility during testing, 
as various clinical scenarios can be simulated simply by vary-
ing parameters of the model while avoiding hardware inter-
ventions. Thus, the performance of active implants and their 
control algorithms, as well as that of passive implants, can be 
evaluated before in-vivo testing. The flexibility and versatility 
of this HMC were proven with three test cases which required 
only software adjustments and the exchange of the device to 
be evaluated.
The principle of operation of the HMC developed is con-
sidered superior to existing approaches. The Donovan mock 
circulation, which is the best-known conventional system, was 
developed in 1975 and was recently used to evaluate the Syn-
Cardia TAH in vitro.22 It constitutes a pure hardware system 
that does not use any numerical model of the cardiovascular 
system. In contrast, in semihybrid systems, some of the com-
ponents of the cardiovascular system are represented by phys-
ical components, such as tubes and tanks to mimic resistances, 
inertances, and compliances. Timms et al.1 introduced such a 
system to evaluate BiVAD cases. The ventricles are imitated 
by pneumatically-actuated chambers, equipped with solenoid 
valves that control the inflow and outflow of the pressurized 
air. A passive diastolic filling of the ventricles is simulated by 
venting these valves. As a result, the system relies on the in-
herent compliance of the trapped air, which may limit the gen-
eration of high-frequency, physiologic waveforms. Arterial and 
pulmonary Windkessel components were similarly imitated 
by proportional-controlled pinch valves to adjust resistances 
and air-trapped reservoirs with adaptable air volume to adjust 
the compliances. Tubes and connections are inevitable in such 
a system. The fluid inertia, which is an important contributor 
to vascular input impedances,23 thus cannot be adjusted as 
desired. Similar approaches have been presented by Scham-
paert et al.,24 who implemented positive displacement pumps 
to represent the ventricles and a polyurethane tube to mimic 
the elastic aortic properties or by Ruiz et al.,25 who used rubber 
bellows actuated by positive displacement pumps to model the 
atria and ventricles. Such semihybrid systems have also been 
used to evaluate a mechanical circulatory support (MCS) de-
vice for the Fontan circulation.26
In mock loops employing physical models of heart valves, 
an adjustment of the desired regurgitant fraction of an insuf-
ficient valve is cumbersome because it must be mechanically 
induced. In our setup, the resistance of the valves toward back-
flow was numerically adjusted (by a change of a parameter 
in software) in such a way that the amount of regurgitation 
matched the one recorded clinically.17 Furthermore, suction 
events with a realistic morphology in pump signals cannot be 
achieved in passive mock loops, which in our case was pos-
sible by using an approach developed earlier.27 However, in-
vestigation and testing of devices under such conditions are 
crucial because these are realistic worst-case scenarios, for 
instance, bearings of rotary blood pumps. Otherwise, such 
events can only be tested with less realistic environments or 
in-vivo trials.
Clinical-use cases during BiVAD and TAH support were 
investigated in the HMC presented; namely experiments with 
AI progression during BiVAD and PVR increase during TAH 
support. When operating these devices at constant speed, the 
problem of the fluid imbalance between systemic and pulmo-
nary circulation was reproduced. Such conditions may lead 
to suction and pulmonary or systemic venous congestion. The 
conditions simulated matched well the published results of 
animal experiments under BiVAD support with and without 
physiologic control.12 We showed that the implementation of 
simple physiologic controllers can mitigate the risk of suction 
or congestion and create more physiologic conditions during 
BiVAD and TAH therapy. However, long-term, implantable 
pressure sensors are required for any clinical implementation 
of these advancements, whose development is still ongoing.28,29
The investigation of TCPC properties under realistic hemo-
dynamic conditions, for instance at rest and exercise, is neces-
sary to verify the results of in-silico studies with computational 
fluid dynamics.21 The combination of closed-loop baroreflex 
functionality and physical hydraulic properties of complex ge-
ometric TCPC structures provides a unique insight into their 
interaction. Employing rapid prototyping techniques, TCPC 
geometries of magnetic resonance (MR)/computed tomog-
raphy (CT) images can be manufactured,21 and pressures as 
well as flow distributions within the TCPC can be investigated 
at a fast pace under various conditions. Therefore, the HMC 
offers a novel, reliable testing environment for passive cardio-
vascular implants and the assessment of their hydraulic proper-
ties in combination with their physiologic effects.
Apart from the cases presented, the HMC developed can be 
used for other experiments, such as evaluating artificial or me-
chanical valves, other grafts with multiple in- or outlets (e.g., 
prosthetic replacements of the aortic arch) as well as for evalu-
ating the use of MCS devices in Fontan patients or the BiVAD 
case with an RVAD pumping from the right atrium to the pul-
monary artery. In general, this versatile HMC can be used for 
any case where one to four pressures interact with an implant.
Limitations
A main limitation of this study is the lack of validation 
of the numerical models used with clinical observations. 
The model14 has been validated for investigating a physio-
logic heart under pre- and afterload changes. By modifying 
that model for our test cases, a new validation is required. 
However, due to the lack of clinical data, this constitutes a 
challenging topic. Only for the circulation with biventricular 
failure9 and for the simulation of AI17 data were available and 
matched the simulated conditions. Despite that, reasonable 
qualitative results were obtained, which matched previous 
animal studies.12 Future study should be focused on validat-
ing these numerical models.
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Conclusion
With its unique versatility and flexibility, the HMC presented 
constitutes a valuable tool for researchers that supports the de-
velopment and investigation of complex active or passive car-
diovascular implants such as TAHs and TCPCs. Its principle of 
operation allows for the generation of realistic pathophysio-
logic signal waveforms and the simulation of various clinical 
conditions. Thus, new devices and their control algorithms can 
be evaluated extensively at an early stage of development. The 
combination of rapid testing of TCPC geometries with such an 
HMC revealed unequal flow distributions and high pressure 
drops at the TCPCs. Such information is crucial and may sup-
port to optimize the TCPC design preoperatively.
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